Lyra Therapeutics, Inc.
CFO
CFO
Lyra Therapeutics, Inc.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
R. Don Elsey is recorded as CFO at Lyra Therapeutics, Inc.. The proxy statement of Lyra Therapeutics, Inc. reports total compensation of $829,442 for R. Don Elsey in fiscal 2021, including a base salary of $350,978. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Lyra Therapeutics, Inc.
CFO
Proxy statement
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
Lyra Therapeutics, Inc.
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Lyra Therapeutics, Inc. | Former Chief Financial Officer | $350,978 | $829,442 |
| 2020 | Lyra Therapeutics, Inc. | Former Chief Financial Officer | $362,558 | $760,686 |
| 2019 | Lyra Therapeutics, Inc. | Chief Financial Officer | $130,625 | $737,778 |
No call appearances or filed executive changes recorded yet.